KCT0009323尚未招募Unknown
Treatment of newly diagnosed high risk pediatric acute lymphoblastic leukemia-prospective, nationwide, multi-center study
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •Age: Under 19years of age at diagnosis
- •- Patients who are newly diagnosed Pre-B ALL and meet one of the following criteria
- •? High-risk group according to the National Cancer Institute (NCI)/Rome: Age greater than or equal to 10 years and less than 19 years at diagnosis, or white blood cell count greater than or equal to 50 x 109/L at diagnosis
- •? If extra-bone marrow lesions are identified at the time of diagnosis, Central nervous system involvement (CNS3) or testicular involvement
- •? High-risk gene variants:
- •KMT2A rearrangement
- •intrachromosomal amplification of chromosome 21 (iAMP21)
- •- Newly diagnosed T cell
排除标准
- •? Patients with Burkitt leukemia/lymphoma or mature B-cell leukemia
- •? Patients with Down syndrome
- •? potential of pregnancy or during pregnancy (patients of childbearing age need adequate contraception for the duration of the trial)
- •? Patients who have already received steroid treatment for newly diagnosed ALL specified in the above selection criteria or chemotherapies more than one intrathecal cytarabine treatment
- •? Participating in an interventional clinical trial other than this research
研究者
相似试验
招募中
2 期
Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic LeukemiaPediatric Acute Lymphoblastic LeukemiaNCT06184009Jae Wook Lee370
招募中
Unknown
Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children.NeoplasmsKCT0009042Samsung Medical Center116
已完成
3 期
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic LeukemiaChildhood Acute Promyelocytic Leukemia With PML-RARAMyeloid NeoplasmNCT00866918Children's Oncology Group106
进行中（未招募）
1 期
Test of the combination of prednisone and everolimus as a new approach in treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with newly diagnosed patientschronic Graft versus Host DiseaseMedDRA version: 14.1Level: LLTClassification code 10018799Term: GVHDSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: LLTClassification code 10063109Term: Transfusion associated GVHDSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: LLTClassification code 10068907Term: CGVHDSystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: LLTClassification code 10018653Term: Graft-versus-host disease <GVHD>System Organ Class: 10021428 - Immune system disordersEUCTR2011-004847-35-DEniversity Medical Center Hamburg-Eppendorf60
招募中
不适用
Treating children with post-traumatic stress disorder (PTSD) following an accidental injuryACTRN12611000902998niversity of Queensland30